JP2022551757A5 - - Google Patents
Info
- Publication number
- JP2022551757A5 JP2022551757A5 JP2022522653A JP2022522653A JP2022551757A5 JP 2022551757 A5 JP2022551757 A5 JP 2022551757A5 JP 2022522653 A JP2022522653 A JP 2022522653A JP 2022522653 A JP2022522653 A JP 2022522653A JP 2022551757 A5 JP2022551757 A5 JP 2022551757A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962915120P | 2019-10-15 | 2019-10-15 | |
| US62/915,120 | 2019-10-15 | ||
| PCT/US2020/055480 WO2021076554A1 (en) | 2019-10-15 | 2020-10-14 | Antibodies targeting flt3 and use thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022551757A JP2022551757A (ja) | 2022-12-13 |
| JPWO2021076554A5 JPWO2021076554A5 (https=) | 2023-10-19 |
| JP2022551757A5 true JP2022551757A5 (https=) | 2023-10-19 |
Family
ID=75538063
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022522653A Ceased JP2022551757A (ja) | 2019-10-15 | 2020-10-14 | Ｆｌｔ３を標的とする抗体およびその使用 |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US20240228628A9 (https=) |
| EP (1) | EP4045537A4 (https=) |
| JP (1) | JP2022551757A (https=) |
| KR (1) | KR20220082882A (https=) |
| CN (1) | CN115348972A (https=) |
| AR (1) | AR120222A1 (https=) |
| AU (1) | AU2020366000A1 (https=) |
| BR (1) | BR112022006817A2 (https=) |
| CA (1) | CA3153801A1 (https=) |
| CL (1) | CL2022000927A1 (https=) |
| CO (1) | CO2022004743A2 (https=) |
| IL (1) | IL292259A (https=) |
| MX (1) | MX2022004291A (https=) |
| PE (1) | PE20221256A1 (https=) |
| TW (1) | TWI867066B (https=) |
| WO (1) | WO2021076554A1 (https=) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EA202091887A1 (ru) | 2018-02-08 | 2020-10-23 | Драгонфлай Терапьютикс, Инк. | Комбинированная терапия рака с применением мультиспецифических связывающих белков, которые активируют естественные клетки-киллеры |
| DK3749346T3 (da) | 2018-02-08 | 2024-09-09 | Dragonfly Therapeutics Inc | Antistof variable domænekombinationer rettet mod nkg2d-receptoren |
| WO2020033630A1 (en) | 2018-08-08 | 2020-02-13 | Dragonfly Therapeutics, Inc. | Multi-specific binding proteins that bind bcma, nkg2d and cd16, and methods of use |
| EA202091888A1 (ru) | 2018-08-08 | 2020-10-23 | Драгонфлай Терапьютикс, Инк. | Вариабельные домены антител, нацеленные на рецептор nkg2d |
| US12378318B2 (en) | 2018-08-08 | 2025-08-05 | Dragonfly Therapeutics, Inc. | Proteins binding NKG2D, CD16 and a tumor-associated antigen |
| EP4291233A4 (en) * | 2021-02-10 | 2025-05-21 | Wugen, Inc. | POLYPEPTIDES AND THEIR USE IN THE TREATMENT OF DISEASES |
| JP2024508894A (ja) | 2021-03-03 | 2024-02-28 | ドラゴンフライ セラピューティクス， インコーポレイテッド | Ｎｋｇ２ｄ、ｃｄ１６、及び腫瘍関連抗原に結合する多特異性結合タンパク質を使用して癌を治療する方法 |
| US12162940B2 (en) | 2021-05-05 | 2024-12-10 | Immatics Biotechnologies Gmbh | BMA031 antigen binding polypeptides |
| WO2023023491A1 (en) * | 2021-08-16 | 2023-02-23 | Hemogenyx Pharmaceuticals Llc | Anti-flt3 antibodies, cars, car t cells and methods of use |
| WO2023105087A1 (en) * | 2021-12-10 | 2023-06-15 | Tubulis Gmbh | Novel flt3 antibodies and antibody-drug-conjugates based thereon, therapeutic methods and uses thereof in combination with tyrosine kinase inhibitors |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR071891A1 (es) * | 2008-05-30 | 2010-07-21 | Imclone Llc | Anticuerpos humanos anti-flt3 (receptor tirosina cinasa 3 tipo fms humano) |
| NL2014108B1 (en) * | 2015-01-09 | 2016-09-30 | Aduro Biotech Holdings Europe B V | Altered april binding antibodies. |
| ES2884844T3 (es) * | 2015-03-09 | 2021-12-13 | Agensys Inc | Conjugados de anticuerpo fármaco (ADC) que se unen a proteínas FLT3 |
| HK1255234A1 (zh) * | 2015-07-16 | 2019-08-09 | 塞勒兰特治疗公司 | 经半胱氨酸取代的免疫球蛋白 |
| CN118772278A (zh) * | 2017-06-02 | 2024-10-15 | 辉瑞公司 | Flt3的特异性抗体及其用途 |
| JP7317718B2 (ja) * | 2017-06-02 | 2023-07-31 | ファイザー・インク | Ｆｌｔ３を標的にするキメラ抗原受容体 |
| WO2019023097A1 (en) * | 2017-07-26 | 2019-01-31 | Smet Pharmaceutical Inc | ASYMMETRIC BISPECIFIC ANTIBODIES AND THEIR USE |
| TW201930344A (zh) * | 2018-01-12 | 2019-08-01 | 美商安進公司 | 抗ｐｄ-１抗體及治療方法 |
-
2020
- 2020-10-14 EP EP20876423.3A patent/EP4045537A4/en active Pending
- 2020-10-14 KR KR1020227016159A patent/KR20220082882A/ko active Pending
- 2020-10-14 BR BR112022006817A patent/BR112022006817A2/pt not_active Application Discontinuation
- 2020-10-14 WO PCT/US2020/055480 patent/WO2021076554A1/en not_active Ceased
- 2020-10-14 PE PE2022000635A patent/PE20221256A1/es unknown
- 2020-10-14 TW TW109135527A patent/TWI867066B/zh active
- 2020-10-14 JP JP2022522653A patent/JP2022551757A/ja not_active Ceased
- 2020-10-14 MX MX2022004291A patent/MX2022004291A/es unknown
- 2020-10-14 US US17/769,257 patent/US20240228628A9/en active Pending
- 2020-10-14 CA CA3153801A patent/CA3153801A1/en active Pending
- 2020-10-14 CN CN202080072320.1A patent/CN115348972A/zh active Pending
- 2020-10-14 AR ARP200102839A patent/AR120222A1/es unknown
- 2020-10-14 AU AU2020366000A patent/AU2020366000A1/en active Pending
-
2022
- 2022-04-12 CL CL2022000927A patent/CL2022000927A1/es unknown
- 2022-04-13 CO CONC2022/0004743A patent/CO2022004743A2/es unknown
- 2022-04-13 IL IL292259A patent/IL292259A/en unknown